Project Grant K08CA300920
Award Date 6/1/26
Completion Date 5/31/31
Dollars Obligated $293K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Ann Arbor, MI 48109, USA
Similar Awards
- Federal Project Grant Award Summary The National Cancer Institute awarded $165,080 to the Regents of the University of Michigan on February 4, 2026, under the Cancer Research Manpower program (CFDA 93.398) to conduct a research study examining guideline-concordant surveillance patterns among young colorectal cancer (CRC) survivors. The project, with an expected completion date of August 31, 2027, will utilize the Michigan Cancer Surveillance Program clinical registry and Michigan Value...
- Federal Grant Award Summary The National Cancer Institute awarded the Regents of the University of Michigan a $2.86 million Project Grant under the Cancer Treatment Research program (CFDA 93.395) to develop and validate a novel microbial-based therapeutic strategy targeting colibactin, a carcinogenic metabolite produced by pathogenic gut bacteria associated with colorectal cancer (CRC). The project, which commenced September 10, 2025, and extends through August 31, 2029, focuses on engineering...
- Federal Project Grant Summary The University of Michigan, Office of Research and Sponsored Projects, received a $319,505 Project Grant from the National Cancer Institute under the Cancer Research Manpower program (CFDA 93.398) awarded August 1, 2025, with completion by July 31, 2030. This five-year award supports the development of comprehensive nationwide training infrastructure in advanced methodological approaches for constructing and optimizing adaptive interventions across the cancer...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded the Regents of the University of Michigan $175,448 under the Cancer Research Manpower program (CFDA 93.398) on January 16, 2026, with completion targeted for July 31, 2027. This project grant supports research training and investigator development in cancer biology, specifically focused on characterizing cancer-associated fibroblasts (CAFs) and their role in pancreatic ductal adenocarcinoma (PDAC). The research aims to...
- Federal Grant Award Summary The National Cancer Institute awarded the University of Michigan $682,272 under the Cancer Cause and Prevention Research program (CFDA 93.393) on September 1, 2025, for a two-year project (completion date August 31, 2027) to assess the feasibility and acceptability of a multifaceted electronic health record (EHR)-integrated mobile health intervention designed to reduce post-operative readmissions following radical cystectomy. The intervention consists of an...
- Federal Project Grant Award Summary The National Cancer Institute (NCI), under its Cancer Research Manpower program (CFDA 93.398), awarded a $297,458 Project Grant to the Regents of the University of Michigan beginning September 1, 2026, and extending through August 31, 2031. This K08 career development award supports Dr. Ameer Elaimy, MD, PhD, in establishing an independent research program focused on improving treatments for gastrointestinal cancers, with particular emphasis on...
- Federal Project Grant Award Summary The University of Michigan's Office of Research and Sponsored Projects received a $171,884 Project Grant award from the National Cancer Institute (NCI) under the Cancer Research Manpower program (CFDA 93.398), effective December 1, 2025, with completion targeted for May 31, 2027. This award supports research aimed at deciphering the functional role of PPP2R1A mutations in cancer, specifically focusing on characterizing the 70% of identified mutations in the...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $136,412 to the Regents of the University of Michigan, effective August 1, 2025 through July 31, 2027, under the Cancer Research Manpower program (CFDA 93.398). This award funds research aimed at defining and interrupting metabolic crosstalk in the glioblastoma microenvironment. The research builds upon preliminary findings demonstrating that glioblastoma (GBM) tumors acquire nutrients through...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded a Project Grant of $544,868 to the Regents of the University of Michigan, Office of Research and Sponsored Projects, under the Cancer Treatment Research program (CFDA 93.395). The award, effective June 1, 2026, through May 31, 2031, supports fundamental research investigating the role of the SLC13A3 transporter and the metabolite itaconate in tumor resistance to immunotherapy. The research addresses a critical gap in...
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded the Regents of the University of Michigan $139,968 under the Cancer Research Manpower program (CFDA 93.398) on July 15, 2025, for a project period extending through June 30, 2027. This Project Grant supports biomedical research training and cancer-related research in basic and translational science aligned with the National Cancer Program priorities. The award funds a research initiative titled "Beyond Lysis:...